Zurcher Kantonalbank (Zurich Cantonalbank) Pacira Bio Sciences, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 10,946 shares of PCRX stock, worth $210,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,946

Previous 10,946 -0.0%

Holding current value

$210,053

Previous $164,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$11.7 - $28.46 $842 - $2,049	-72 Reduced 0.65%	10,946 $164,000
Q2 2024 Jul 29, 2024	BUY	$25.5 - $31.51 $790 - $976	31 Added 0.28%	11,018 $315,000
Q1 2024 Apr 25, 2024	BUY	$27.7 - $35.48 $415 - $532	15 Added 0.14%	10,987 $321,000
Q4 2023 Jan 30, 2024	BUY	$26.32 - $34.31 $684 - $892	26 Added 0.24%	10,972 $370,000
Q3 2023 Oct 25, 2023	BUY	$30.68 - $40.09 $84,799 - $110,808	2,764 Added 33.78%	10,946 $335,000
Q1 2023 May 08, 2023	BUY	$35.53 - $43.38 $29,809 - $36,395	839 Added 11.43%	8,182 $333,000
Q4 2022 Feb 01, 2023	BUY	$38.19 - $57.45 $22,226 - $33,435	582 Added 8.61%	7,343 $283,000
Q2 2022 Aug 09, 2022	SELL	$51.49 - $81.64 $2,008 - $3,183	-39 Reduced 0.57%	6,761 $394,000
Q1 2022 Apr 21, 2022	BUY	$60.03 - $76.49 $31,215 - $39,774	520 Added 8.28%	6,800 $519,000
Q4 2021 Feb 01, 2022	BUY	$47.97 - $62.21 $110,426 - $143,207	2,302 Added 57.87%	6,280 $378,000
Q1 2021 May 03, 2021	SELL	$59.31 - $78.82 $92,879 - $123,432	-1,566 Reduced 28.25%	3,978 $279,000
Q2 2020 Jul 28, 2020	BUY	$30.8 - $52.47 $23,223 - $39,562	754 Added 15.74%	5,544 $291,000
Q1 2020 May 06, 2020	BUY	$28.4 - $50.7 $68,955 - $123,099	2,428 Added 102.79%	4,790 $161,000
Q1 2019 Apr 29, 2019	SELL	$36.47 - $42.17 $21,444 - $24,795	-588 Reduced 19.93%	2,362 $90,000
Q4 2018 Jan 25, 2019	BUY	$41.31 - $52.16 $22,224 - $28,062	538 Added 22.31%	2,950 $127,000
Q3 2018 Nov 09, 2018	BUY	$32.85 - $52.0 $14,059 - $22,256	428 Added 21.57%	2,412 $119,000
Q4 2017 Jan 31, 2018	BUY	$31.85 - $46.95 $16,434 - $24,226	516 Added 35.15%	1,984 $91,000
Q3 2017 Nov 08, 2017	BUY	$35.7 - $39.5 $52,407 - $57,986	1,468	1,468 $55,000

Others Institutions Holding PCRX

# of Institutions

264

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $879M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Pacira Bio Sciences, Inc. Transaction History